title: Epstein-Barr virus infection and human malignancies.
abstract: The Epstein-Barr virus (EBV) is a herpes virus which establishes a life-long persistent infection in over 90% of the human adult population world-wide. Based on its association with a variety of lymphoid and epithelial malignancies, EBV has been classified as a group 1 carcinogen by the International Agency for Research on Cancer. In this article we discuss the evidence supporting an aetiological role for EBV in the pathogenesis of human tumours. The biology of EBV infection will be described with special emphasis on viral transforming gene products. A brief survey of EBV-associated tumours is followed by a discussion of specific problems. Evidence is presented which suggests that failures of the EBV-specific immunity may play a role in the pathogenesis of EBV-associated tumours also in patients without clinically manifest immunodeficiencies. Finally, the timing of EBV infection in the pathogenesis of virus-associated malignancies is discussed. There is good evidence that EBV infection precedes expansion of the malignant cell populations in some virus-associated tumours. However, this is clearly not always the case and for some of these tumours there are indications that clonal genetic alterations may occur prior to EBV infection. Thus, whilst there is good evidence to suggest that EBV is a human carcinogen, its precise role(s) in the development of virus-associated human tumours requires clarification.
authors.affiliation: Pathologisches Institut, Friedrich-Alexander-Universität, Krankenhausstr. 8-10, 91054 Erlangen, Germany. gerald.niedobitek @patho.imed.uni-erlangen.de
authors.forename: G
authors.initials: G
authors.lastname: Niedobitek
authors.forename: N
authors.initials: N
authors.lastname: Meru
authors.forename: H J
authors.initials: HJ
authors.lastname: Delecluse
mesh_terms: D002051:Burkitt Lymphoma / Q000821:virology; D004854:Herpesvirus 4, Human / Q000472:pathogenicity*; D006689:Hodgkin Disease / Q000821:virology; D006801:Humans; D007244:Infectious Mononucleosis / Q000821:virology; D008223:Lymphoma / Q000821:virology; D008228:Lymphoma, Non-Hodgkin / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000821:virology; D009303:Nasopharyngeal Neoplasms / Q000821:virology; D009856:Oncogene Proteins, Viral / Q000378:metabolism*; D014412:Tumor Virus Infections / Q000235:genetics / Q000276:immunology / Q000378:metabolism
chemical_list: D009856:Oncogene Proteins, Viral